ConductScience.org, home

Paper48253

Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation.

Hahn GM and 2 others. Proc Natl Acad Sci U S A, 1975. Cited by 508 papers, by iCite.

Cite this record

ConductScience Library. Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation. Papers, record 48253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/48253

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1975
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
508
iCite
Relative citation ratio, by iCite
15.6
iCite
Revised in PubMed
2019-05-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hahn GMG M
2Braun JJ
3Har-Kedar II

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BleomycinMajor topic
DoxorubicinMajor topic
Hot TemperatureMajor topic
Mammary Neoplasms, ExperimentalMajor topic
Sarcoma, ExperimentalMajor topic
Animals
Cell Line
Cell Survival
Cricetinae
Mice
Mice, Inbred BALB C
Neoplasm Transplantation

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14121070Effect of bleomycin on mammalian cell survival.J Natl Cancer Inst1972https://conductscience.org/library/papers/4121070PubMed
24121931Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure.J Natl Cancer Inst1973https://conductscience.org/library/papers/4121931PubMed
34122362A clinical review of bleomycin--a new antineoplastic agent.Cancer1973https://conductscience.org/library/papers/4122362PubMed
44128424Cell survival and repair of plateau-phase cultures after chemotherapy--relevance to tumor therapy and to the in vitro screening of new agents.Cancer Chemother Rep1973https://conductscience.org/library/papers/4128424PubMed
54138162Metabolic aspects of the role of hyperthermia im mammalian cell inactivation and their possible relevance to cancer treatment.Cancer Res1974https://conductscience.org/library/papers/4138162PubMed
64292219Selective heat sensitivity of cancer cells. Biochemical and clinical studies.Cancer1967https://conductscience.org/library/papers/4292219PubMed
74634086Thermal enhancement of thio-TEPA cytotoxicity.J Natl Cancer Inst1973https://conductscience.org/library/papers/4634086PubMed
84695229Cellular radiosensitivity and tumor radiation response in the EMT6 tumor cell system.Radiat Res1973https://conductscience.org/library/papers/4695229PubMed
94748422Selective lethal effect of supranormal temperatures on mouse sarcoma cells.Cancer Res1973https://conductscience.org/library/papers/4748422PubMed
105481703Daunomycin metabolism in rat tissue slices.J Pharmacol Exp Ther1970https://conductscience.org/library/papers/5481703PubMed
115541516Molecular motion in spin-labeled phospholipids and membranes.J Am Chem Soc1971https://conductscience.org/library/papers/5541516PubMed
125761385Chinese hamster cell monolayer cultures. I. Changes in cell dynamics and modifications of the cell cycle with the period of growth.Exp Cell Res1968https://conductscience.org/library/papers/5761385PubMed
135794423Adriamycin (14-hydroxydaunomycin), a novel antitumor antibiotic.Tetrahedron Lett1969https://conductscience.org/library/papers/5794423PubMed
145929561Chromosome aberrations induced by thymidine.Exp Cell Res1966https://conductscience.org/library/papers/5929561PubMed
155953301New antibiotics, bleomycin A and B.J Antibiot (Tokyo)1966https://conductscience.org/library/papers/5953301PubMed

Download CSV of references

Cited by81

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 508 citations.

PMIDTitleJournalYearIn PapersSource
41708120Present and future of cytoreductive surgery and hyperthermic intrathoracic chemotherapy for pleural metastases: a narrative review.Eur Respir Rev2026https://conductscience.org/library/papers/41708120PubMed
41083760Recent advances in metallic nanostructure-based photothermal therapy in the management of cancer metastasis.Med Oncol2025https://conductscience.org/library/papers/41083760PubMed
38534622Development of pH-Responsive, Thermosensitive, Antibacterial, and Anticancer CS/PVA/Graphene Blended Hydrogels for Controlled Drug Delivery.Gels2024https://conductscience.org/library/papers/38534622PubMed
37559173Photothermal-Triggered Sulfur Oxide Gas Therapy Augments Type I Photodynamic Therapy for Potentiating Cancer Stem Cell Ablation and Inhibiting Radioresistant Tumor Recurrence.Adv Sci (Weinh)2023https://conductscience.org/library/papers/37559173PubMed
36233653
The Role of Intraperitoneal Intraoperative Chemotherapy with Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis from Ovarian Cancer-Hyperthermia versus Normothermia: A Randomized Controlled Trial.
J Clin Med2022https://conductscience.org/library/papers/36233653PubMed
35540837A pH and magnetic dual-response hydrogel for synergistic chemo-magnetic hyperthermia tumor therapy.RSC Adv2018https://conductscience.org/library/papers/35540837PubMed
33803677880 nm NIR-Triggered Organic Small Molecular-Based Nanoparticles for Photothermal Therapy of Tumor.Nanomaterials (Basel)2021https://conductscience.org/library/papers/33803677PubMed
33483518A hybrid semiconducting organosilica-based O2 nanoeconomizer for on-demand synergistic photothermally boosted radiotherapy.Nat Commun2021https://conductscience.org/library/papers/33483518PubMed
32917589Novel fractionated ultrashort thermal exposures with MRI-guided focused ultrasound for treating tumors with thermosensitive drugs.Sci Adv2020https://conductscience.org/library/papers/32917589PubMed
32887622Internal cross-linked polymeric nanoparticles with dual sensitivity for combination therapy of muscle-invasive bladder cancer.J Nanobiotechnology2020https://conductscience.org/library/papers/32887622PubMed
31696114Recent Advances in Nanomaterials-Based Chemo-Photothermal Combination Therapy for Improving Cancer Treatment.Front Bioeng Biotechnol2019https://conductscience.org/library/papers/31696114PubMed
31462676Pulsed-wave Ultrasound Hyperthermia Enhanced Nanodrug Delivery Combined with Chloroquine Exerts Effective Antitumor Response and Postpones Recurrence.Sci Rep2019https://conductscience.org/library/papers/31462676PubMed
31448377Her2-Functionalized Gold-Nanoshelled Magnetic Hybrid Nanoparticles: a Theranostic Agent for Dual-Modal Imaging and Photothermal Therapy of Breast Cancer.Nanoscale Res Lett2019https://conductscience.org/library/papers/31448377PubMed
31345068Increased uptake of doxorubicin by cells undergoing heat stress does not explain its synergistic cytotoxicity with hyperthermia.Int J Hyperthermia2019https://conductscience.org/library/papers/31345068PubMed
30226898Triggered radiosensitizer delivery using thermosensitive liposomes and hyperthermia improves efficacy of radiotherapy: An in vitro proof of concept study.PLoS One2018https://conductscience.org/library/papers/30226898PubMed
30128039
Thermo- and pH-dual responsive polymeric micelles with upper critical solution temperature behavior for photoacoustic imaging-guided synergistic chemo-photothermal therapy against subcutaneous and metastatic breast tumors.
Theranostics2018https://conductscience.org/library/papers/30128039PubMed
30001990Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial.Lancet Oncol2018https://conductscience.org/library/papers/30001990PubMed
29659611Preoperative evaluation of the efficacy of radio-hyperthermo-chemotherapy for soft tissue sarcoma in a case series.PLoS One2018https://conductscience.org/library/papers/29659611PubMed
29479833Clinical outcomes of radio-hyperthermo-chemotherapy for soft tissue sarcoma compared to a soft tissue sarcoma registry in Japan: a retrospective matched-pair cohort study.Cancer Med2018https://conductscience.org/library/papers/29479833PubMed
29266476Activatable Hybrid Nanotheranostics for Tetramodal Imaging and Synergistic Photothermal/Photodynamic Therapy.Adv Mater2018https://conductscience.org/library/papers/29266476PubMed

See all 81 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/48253

GET https://conductscience.org/api/papers/v1/48253/cited_by?page=2